Company Overview and News

 
Of 85 Utilities, 19 Show 'Safer' Dividends Through April 2019

2018-04-11 seekingalpha
19 of 85 Utilities stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash-flow yields greater than their dividend yields.
Upvote Downvote

 
Your Utilities Top Yield Stocks Per April Stats

2018-04-11 seekingalpha
PEGI, TERP, & AY led the top-ten Utilities pack per analyst-targeted price gains with combined 25.5% average net-gains, while 7 trailing combined for 14.8% average gains estimated 4/9/18.
Upvote Downvote

 
PEGI / Pattern Energy Group Inc. / CI INVESTMENTS INC. - null (Passive Investment)

2018-04-09 sec.gov
UNITED STATES Securities and Exchange Commission Washington, D. C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. _ ) PATTERN ENERGY GROUP INC Common Stock CUSIP Number 70338P100 Date of Event Which Requires Filing of this Statement: March 27, 2018 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ x ] Rule 13d-1(c) [ ] Rule 13d-1(d) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1) Name of reporting person: Signature Global Asset Management (the "Investment Manager") A Business Unit of
Upvote Downvote

 
If I Had To Build An Income Portfolio Today - Update 28

2018-04-09 seekingalpha
This article is Update 28 to my original article entitled "If I Had to Build An Income Portfolio Today."
Upvote Downvote

 
Building The Perfect Beast: The Brown Bag Portfolio April Update

2018-04-02 seekingalpha
The other day I was asked by one of my readers: "Do you know how much new money you will have to contribute to the BBP each year (month) to reach your dividend goal?" My immediate thought was "Yes, of course - if I can maintain a yield of 6.6% I will need approximately $250,000." Therefore if I have approximately $20,000 invested now and with an approximate 15 year horizon, that leaves me investing $15,333 a year over the next 15 years, or $1277.
Upvote Downvote

1
24 'Safer' Dividends Out Of My Readers 49 Most Mentioned Dividend Stocks For March

2018-03-25 seekingalpha
From 2/1-3/5/18, Fredrik Arnold dividend "followers" discussed 49 equities and funds in their messages and comments. Some comments were bad news, so bad rogues mixed into a FollowerFavorite/Rogue (FoFa/Ro) list.
Upvote Downvote

 
27 Russell 3000 'Safer' Dividend Stocks: A Bevy Of REITs For March

2018-03-20 seekingalpha
27 of 95 Russell 3000 Index stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields 3/15/18.
Upvote Downvote

 
20 Top Russell 3000 REITs Gain 10% To 37% Per Broker March Targets

2018-03-19 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
Upvote Downvote

3
Dividend Sensei's Portfolio Update 26: Let The Next Market Crash Make You Rich

2018-03-13 seekingalpha
The bull market just turned nine, but history and positive fundamentals indicate that it might have many more years to run.
Upvote Downvote

1
Meet Wall Street's Star 26 'Safer' Dividend Stocks For March 2019

2018-03-13 seekingalpha
Wall Street thrives on picking prices for equities. Nearly all my articles include Broker 1yr. Target estimates. This Wall St. Star series was suggested by a reader, Minnesota72.
Upvote Downvote

1
Don't Miss This High-Yielding Renewable YieldCo

2018-03-12 seekingalpha
CAFD projected to continue to grow, whilst dividends per share growth will slow to increase the coverage ratio.
Upvote Downvote

1
Pattern Energy Group: A Fascinating Utility; Higher Yield But Higher Risk

2018-03-10 seekingalpha
Out of 29 diversified utilities, Pattern Energy Group (PEGI) is the 9th smallest, with a market capitalization of $1.74 billion. They have the 3rd highest PE (402.25) and 5th highest forward PE (22.25). They also have the highest dividend yield (9.55%).
Upvote Downvote

1
8point3: Where Do I Go From Here?

2018-03-08 seekingalpha
Recent investors in 8point3 Energy Partners LP (CAFD) were aware that both sponsors were looking to remove the yieldco from their balance sheets and were actively accepting offers to buy out 8point3. on Feb 5th, 8point3 announced it accepted an offer from Capital Dymanics for 12.35 per unit. This caused the share price to drop from $13.81 to $12.14 almost instantly. This sale is expected to be completed by Q2 or Q3 of 2018.
Upvote Downvote

 
Dividend Sensei's Portfolio Update 25: Invest Against The Crowd If You Want To Get Rich

2018-03-06 seekingalpha
Another hard week for high-yield stocks especially: REITs, MLPs, and utilities created even more amazing buying opportunities.
Upvote Downvote

 
Trouble On The Horizon? The Brown Bag Portfolio March Update

2018-03-05 seekingalpha
Wow, February was uncomfortable, and as I write this update March looks like it may be turbulent to say the least. Rising rates, threatened tariffs, and investor skittishness have all combined to make owning high-yielding equities difficult. Timing, they say, is everything and if that’s the case then my timing sucks! But - and let’s be honest, you were expecting a "but" - I remain undeterred.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 70338P100